Our technology

Building Transformative Therapeutics Through Simulation

The unparalleled accuracy of our technology grants unprecedented insights into drug mechanisms, allowing us and our partners to pursue truly groundbreaking therapeutic strategies.

Learn More

Our Mission

Unlocking Undruggable Targets

Our core technology has been built to succeed where status quo in-silico drug design fails. We’ve raised the bar for simulation accuracy, putting previously inaccessible targets and modalities into play.

About Us

Recent News & Events

May 7, 2026

Our CEO, Dr. Anthony Fejes, and Director of Business Development, Jacek Mis, will be in San Diego, June 22-25 at the 2026 BIO International Convention. Connect with us through the partnering portal or email us directly at info@htuobio.com to learn about our technology and its drug discovery potential.

April 21, 2026

HTuO is proud to be selected as one of the “Sweet 16” for Sweet Biopharma Day on April 29. Our CEO, Anthony Fejes, will be presenting our technology at the Sucrerie Bonaventure in Mirabel, to a curated group of pharmaceutical industry leaders, investors, and life sciences organizations. We are honoured to be part of this cohort and look forward to the event!

March 12, 2026

Dr. Yi-Hsuan Lin, our R&D Lead, and Dr. Mathew Neal, our Computational Chemistry Application Scientist, will present HTuO’s poster at ACS Spring 2026 happening in Atlanta, March 22-26, 2026. They will be at poster #22 in room B3/B4 (Exhibit Hall) on Tuesday, March 24, 6 PM - 8 PM to share about HTuO’s technology.

View All News & Events
Team Image

Interested in working with us?

Join the HTuO Team

Check our Careers page for open positions, and see if we have the right opportunity for you.

Open Positions